Rubius Therapeutics' Series C Round

Rubius Therapeutics raised a round of funding on March 01, 2018.

Rubius Therapeutics is developing Red-Cell Therapeutics (RCTs) as a new treatment modality to address a wide array of indications including cancer, autoimmune disease, rare disease and metabolic disea…

Articles about Rubius Therapeutics' Series C Round: